Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Xiaozhai Yu"'
Autor:
Zixiang Ye, Enmin Xie, Yanxiang Gao, Peizhao Li, Yimin Tu, Ziyu Guo, Qing Li, Yaxin Wu, Xiaozhai Yu, Yike Li, Changan Yu, Jingang Zheng
Publikováno v:
BMC Endocrine Disorders, Vol 22, Iss 1, Pp 1-8 (2022)
Abstract Objective We aimed to investigate the association between triglyceride glucose index and cardiovascular disease (CVD) development in the Chinese middle-aged and elderly population using the China Health and Retirement Longitudinal Study data
Externí odkaz:
https://doaj.org/article/181f625b1a654c2fa28555c08b4f1237
Autor:
Zixiang Ye, Enmin Xie, Siqi Jiao, Yanxiang Gao, Peizhao Li, Yimin Tu, Ziyu Guo, Qing Li, Yaxin Wu, Xiaozhai Yu, Yike Li, Changan Yu, Jingyi Ren, Jingang Zheng
Publikováno v:
BMC Cardiovascular Disorders, Vol 22, Iss 1, Pp 1-8 (2022)
Abstract Objective We aimed to investigate the effect of the triglyceride glucose (TyG) index on the association between diabetes and cardiovascular disease (CVD). Methods Data from 6,114 individuals were extracted and analyzed from the China Health
Externí odkaz:
https://doaj.org/article/2f77972b78b6493a821a148ae618a0fb
Autor:
Yaxin Wu, Yanxiang Gao, Qing Li, Chao Wu, Enmin Xie, Yimin Tu, Ziyu Guo, Zixiang Ye, Peizhao Li, Yike Li, Xiaozhai Yu, Jingyi Ren, Jingang Zheng
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
BackgroundChronic kidney disease (CKD) patients have a high prevalence of coronary artery disease and a high risk of cardiovascular events. The present study assessed the value of the CHA2DS2-VASc score for predicting mortality among hospitalized acu
Externí odkaz:
https://doaj.org/article/683d13784a8e41e380f3a389a22e8565
Autor:
Zixiang Ye, Yaxin Wu, Yimin Tu, Mulei Chen, Yanxiang Gao, Linying Shi, Peizhao Li, Enmin Xie, Ziyu Guo, Qing Li, Xiaozhai Yu, Yike Li, Wenquan Niu, Jingyi Ren, Jingang Zheng
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 8 (2022)
ObjectiveOur study aims to investigate the role of the ABO blood group in the development and severity of coronary artery disease (CAD) in end-stage renal disease (ESRD) patients with dialysis.MethodsA total of 408 ESRD patients with dialysis between
Externí odkaz:
https://doaj.org/article/eb98c69f33b545c48e5c8fa9002a8d3c
Autor:
Qing, Li, Enmin, Xie, Yimin, Tu, Yaxin, Wu, Ziyu, Guo, Peizhao, Li, Yike, Li, Xiaozhai, Yu, Zixiang, Ye, Changan, Yu, Yanxiang, Gao, Zheng, Jingang
Publikováno v:
International Journal of Cardiology. 369:13-18
ST-segment elevation myocardial infarction (STEMI) patients with a high thrombus burden have a relatively high slow-flow/no-reflow risk. However, the association between kaolin-induced maximum amplitude (MAsubthrombin/sub) and slow-flow/no-reflow has
Autor:
Zixiang Ye, Yaxin Wu, Yimin Tu, Mulei Chen, Yanxiang Gao, Linying Shi, Peizhao Li, Enmin Xie, Ziyu Guo, Qing Li, Xiaozhai Yu, Yike Li, Wenquan Niu, Jingyi Ren, Jingang Zheng
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 8 (2022)
ObjectiveOur study aims to investigate the role of the ABO blood group in the development and severity of coronary artery disease (CAD) in end-stage renal disease (ESRD) patients with dialysis.MethodsA total of 408 ESRD patients with dialysis between
Autor:
Yaxin, Wu, Yanxiang, Gao, Qing, Li, Chao, Wu, Enmin, Xie, Yimin, Tu, Ziyu, Guo, Zixiang, Ye, Peizhao, Li, Yike, Li, Xiaozhai, Yu, Jingyi, Ren, Jingang, Zheng
Publikováno v:
Frontiers in cardiovascular medicine. 9
Chronic kidney disease (CKD) patients have a high prevalence of coronary artery disease and a high risk of cardiovascular events. The present study assessed the value of the CHAThis was a retrospective cohort study that included CKD patients who were